铁和与铁相关的长非编码RNA在乳腺癌中的作用
Shasha Xiang1,2, Wen Yan1, Xing Ren2
1Cancer Research Institute, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Cellular & molecular biology letters
|March 26, 2024
概括
研究与铁亡相关的长非编码RNA (lncRNAs) 为乳腺癌提供了新的治疗策略. 了解这些ferroptosis lncRNAs可能会导致新的生物标志物和改进的癌症治疗方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 铁亡是一种调节的细胞死亡途径,对癌症治疗至关重要,由铁依赖的脂质过氧化驱动.
- 长非编码RNAs (lncRNAs) 在与传统疗法相结合时,显示出增强抗癌治疗和降低死亡率的潜力.
- 识别与铁亡相关的 lncRNA 是开发乳腺癌创新治疗策略的关键.
研究的目的:
- 探索与铁亡相关的 lncRNAs 在乳腺癌 (BC) 中的作用.
- 为了识别BC.潜在的铁与铁相关的lncRNA生物标志物.
- 调查BC中铁灭机制和lncRNA之间的相关性.
主要方法:
- 铁灭的途径的审查,包括铁和反应性氧物种 (ROS) 的代谢.
- 讨论关键的铁灭系统:XC-/GSH/GPX4,ACSL4/LPCAT3/15-LOX,以及FSP1/CoQ10/NAD.
- 在乳腺癌的背景下,分析铁和lncRNAs之间的相互作用.
主要成果:
- 铁亡涉及调节铁和ROS代谢的关键通路.
- lncRNAs参与调节铁亡,表明它们作为治疗点或生物标志物的潜力.
- 特定的与铁亡相关的lncRNAs可能作为乳腺癌的预测或预后标记物.
结论:
- 与铁亡相关的lncRNAs代表了新型乳腺癌治疗的有希望的途径.
- 对这些lncRNA的进一步研究可能会发现新的生物标志物,从而改善患者的治疗结果.
- 向由lncRNAs调节的铁亡途径可能会提高现有癌症治疗的疗效.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
The Nucleolus
8.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
Formation of Muscle Fibers from Myoblasts
4.9K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
4.9K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


